Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. Deng H, Bernier SG, Doyle E, Lorusso J, Morgan BA, Westlin WF, Evindar G ACS Med Chem Lett. 2013 Oct 10; 4(10):942-7. Epub 2013 Aug 27. PMID: 24900589. Abstract CommentRecommendBookmarkWatch